Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prognostic value of hypertension timing for survival in glioblastoma patients receiving bevacizumab: a retrospective single centre analysis

Journal of Neuro-Oncology(2025)10.1007/s11060-025-05209-4Source: DataRank Database

Prognostic value of hypertension timing for survival in glioblastoma patients receiving bevacizumab: a retrospective single centre analysis is a research paper published in Journal of Neuro-Oncology (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.00)OA: closedTopics (44)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Atsushi Kambe ORCID,Hidefumi Amisaki,Tomohiro Hosoya,Makoto Sakamoto ORCID,Masamichi Kurosaki ORCID

Live enrichment

PubMed:40924324 OpenAlex:https://openalex.org/W4414081320

Japan Society for the Promotion of Science

Grant: JP23K08520

FWCI

0.00

Citation Percentile

0.3%

closedLicense: https://www.springernature.com/gp/researchers/text-and-data-mining

publisherhttps://link.springer.com/content/pdf/10.1007/s11060-025-05209-4.pdf

publisherhttps://link.springer.com/article/10.1007/s11060-025-05209-4/fulltext.html

journalhttps://doi.org/10.1007/s11060-025-05209-4

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40924324

Fields of Study

Glioma Diagnosis and TreatmentAngiogenesis and VEGF in CancerBrain Metastases and TreatmentHumansBevacizumabGlioblastomaMaleFemaleRetrospective StudiesHypertensionMiddle AgedBrain NeoplasmsPrognosisAgedAdultAntineoplastic Agents, ImmunologicalTime FactorsFollow-Up Studies

MeSH Terms

BevacizumabAntineoplastic Agents, ImmunologicalAdultAgedBrain NeoplasmsFemaleFollow-Up StudiesGlioblastomaHumansHypertensionMaleMiddle AgedPrognosisRetrospective StudiesTime Factors

Keywords

GlioblastomaBlood pressureValue (mathematics)Retrospective cohort studyBiomarkerOverall survivalSurvival analysisHypertensionSurvivaltimingBevacizumab